Apyx Medical (APYX) Stock Price, News & Analysis

Company Overview

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Key Stats

• Today's Range: $1.45 to $1.51
• 50-Day Range: $1.36 to $1.76
• 52-Week Range: $0.97 to $2.30
• Volume: 6,061 shs
• Average Volume: 27,108 shs
• Market Capitalization: $56.84 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Moderate Buy

Apyx Medical Stock Analysis - MarketRank™

Apyx Medical scored higher than 29% of companies evaluated by MarketBeat, and ranked 795th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Apyx Medical.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Apyx Medical are expected to grow in the coming year, from ($0.68) to ($0.33) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Apyx Medical is -1.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Apyx Medical is -1.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Apyx Medical has a P/B Ratio of 1.94. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.47% of the float of Apyx Medical has been sold short.

Short Interest Ratio / Days to Cover

Apyx Medical has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Apyx Medical has recently increased by 0.40%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Apyx Medical does not currently pay a dividend.

Dividend Growth

Apyx Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 4.2 / 5
• Environmental Score: -1.07

Percentage of Shares Shorted

0.47% of the float of Apyx Medical has been sold short.

Short Interest Ratio / Days to Cover

Apyx Medical has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Apyx Medical has recently increased by 0.40%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Apyx Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

16.80% of the stock of Apyx Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

55.33% of the stock of Apyx Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

APYX Stock Analysis - Frequently Asked Questions

How have APYX shares performed this year?

Apyx Medical's stock was trading at $1.58 at the start of the year. Since then, APYX stock has decreased by 4.4% and is now trading at $1.51.
View the best growth stocks for 2025 here.

How were Apyx Medical's earnings last quarter?

Apyx Medical Co. (NASDAQ:APYX) released its earnings results on Friday, November, 8th. The company reported ($0.14) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.01. The business earned $11.49 million during the quarter, compared to analysts' expectations of $11.66 million. Apyx Medical had a negative trailing twelve-month return on equity of 137.98% and a negative net margin of 58.59%.

Who are Apyx Medical's major shareholders?

Top institutional shareholders of Apyx Medical include Nantahala Capital Management LLC (8.42%), Archon Capital Management LLC (8.34%), Royce & Associates LP (6.95%) and Taylor Frigon Capital Management LLC (1.45%). Insiders that own company stock include Charles D Goodwin II and Todd Hornsby.
View institutional ownership trends.

How do I buy shares of Apyx Medical?

Shares of APYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Apyx Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Apyx Medical investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), DiamondRock Hospitality (DRH), AUO (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM).

Company Calendar

• Last Earnings: 11/08/2024
• Today: 2/21/2025
• Next Earnings (Estimated): 5/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:APYX
• CUSIP: N/A
• CIK: 719135
• Web: www.apyxmedical.com
• Phone: (727) 384-2323
• Fax: 800-323-1640
• Employees: 270
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.83)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-18,710,000.00
• Net Margins: -58.59%
• Pretax Margin: -58.25%
• Return on Equity: -137.98%
• Return on Assets: -36.74%

Debt

• Debt-to-Equity Ratio: 3.03
• Current Ratio: 5.46
• Quick Ratio: 4.52

Sales & Book Value

• Annual Sales: $48.54 million
• Price / Sales: 1.17
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.78 per share
• Price / Book: 1.94

Miscellaneous

• Outstanding Shares: 37,644,000
• Free Float: 31,320,000
• Market Cap: $56.84 million
• Optionable: Optionable
• Beta: 1.25